From histological and molecular pathology to the inclusion of antibody-drug conjugates in clinical practice against ovarian cancers: Mechanisms of action and pharmacological safety
{{output}}
Approximately 75% of the ovarian cancer (OC) patients are diagnosed in advanced stages and platinum-based chemotherapy presents severe side effects and high recurrence rates. This narrative review consolidates current knowledge and describes the pathophysiolog... ...